ArticleBioinformatics advances2026
Rosace-AA: enhancing interpretation of deep mutational scanning data with amino acid substitution and position-specific insights.
Article in Bioinformatics advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Scanning the horizon: deep mutational scanning approaches in virology.Journal of virology · 2026Review
- Accurate variant effect estimation in FACS-based deep mutational scanning data with Lilace.Genome biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Motivation: Proteins are dynamic systems whose function and behavior are sensitive to environmental conditions and often involve multiple cellular roles. Deep mutational scanning (DMS) experiments generate extensive datasets to capture the functional consequences of mutations. However, the sheer volume of data presents challenges in visualization and interpretation. Current approaches often rely on heatmaps, but these methods fail to capture the nuanced effects of amino acid substitutions, which are essential for understanding mutational impact. Results: To address this, we extend the Rosace framework with Rosace-AA, a model that incorporates both position-specific information and amino acid substitution trends. Using substitution matrices like BLOSUM90, Rosace-AA infers an interpretable score from the raw counts of growth-based DMS data, on both protein-level and at the position-level while simultaneously inferring the effect of each variant. We demonstrate its utility across datasets, including OCT1 and MET kinase, showing that Rosace-AA highlights key positions where mutations deviate from expected substitution patterns and captures functionally relevant variation in protein behavior across multiple DMS screens. These results suggest that Rosace-AA enables more robust and interpretable analysis of complex DMS datasets. Availability and implementation: An implementation of Rosace-AA as an R package and vignettes can be found at this repository: https://github.com/pimentellab/rosace-aa. Scripts for processing data and generating figures in this article are also available on GitHub (https://github.com/roserao/rosaceaa-paper-script).
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.